TANG CAPITAL PARTNERS LP 13D and 13G filings for Reviva Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:00 pm Purchase | 2023-12-31 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | TANG CAPITAL PARTNERS LP | 154,931 9.990% | 41,620 (+36.73%) | Filing |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | TANG CAPITAL PARTNERS LP | 113,311 9.990% | 45,802 (+67.85%) | Filing |
| 2021-06-03 08:30 am Purchase | 2021-05-27 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | TANG CAPITAL PARTNERS LP | 67,509 9.990% | 67,509 (New Position) | Filing |